CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,577
- in 1 filing
Net −$24,577. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-09 | Zerhouni Elias A. Vice Chairman and President | Grant or award | +19,777,514 | 19,777,514 | ||
| 2022-05-09 | Zerhouni Elias A. Vice Chairman and President | Grant or award | +19,777,514 | 19,777,514 | ||
| 2022-05-09 | Borisy Alexis Director | Grant or award | +312,612 | 312,612 | ||
| 2022-05-09 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-05-09 | Nabel Gary J. Chief Innovation Officer | Grant or award · Stock Option (Right to Buy) | +34,923 | 34,923 | ||
| 2022-05-09 | Zerhouni Elias A. Vice Chairman and President | Grant or award · Stock Option (Right to Buy) | +34,923 | 34,923 | ||
| 2022-05-09 | Borisy Alexis Director | Grant or award | +312,612 | 312,612 | ||
| 2022-05-09 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-03-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +9,955 | $3.03 | $30K | 194,731,649 |
| 2022-03-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +9,200 | $3.03 | $28K | 194,740,849 |
| 2022-03-14 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +15,845 | $3.05 | $48K | 194,756,694 |
| 2022-03-11 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +100 | $3.12 | $312 | 194,621,794 |
| 2022-03-11 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +26,863 | $3.13 | $84K | 194,648,657 |
| 2022-03-11 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +73,037 | $3.13 | $229K | 194,721,694 |
| 2022-02-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +4,700 | $3.09 | $14K | 194,526,394 |
| 2022-02-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +300 | $3.09 | $927 | 194,526,694 |
| 2022-02-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +10,375 | $3.10 | $32K | 194,537,069 |
| 2022-02-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +420 | $3.10 | $1K | 194,537,489 |
| 2022-02-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +49,205 | $3.11 | $153K | 194,586,694 |
| 2022-02-28 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | +15,000 | $3.12 | $47K | 194,601,694 |
Page 25 of 33 · 653 trades